AlzeCure Pharma AB (publ) announced that An van Es-Johansson is joining the company's management team. In doing so, she is directly involved in the development of AlzeCure's candidate portfolio. She has resigned from AlzeCure Pharma AB's Board of Directors as a result of the new position. An van Es-Johansson will as of March 3, 2020 be part of AlzeCure Pharma's management team as Chief Medical Officer and Head of Development. She thus leaves AlzeCure Pharma's board with immediate effect. She is an entrepreneur and also a board member of BioInvent, Agendia, Savara Pharmaceuticals, PLUS Therapeutics and Medivir.